Ann Geiger, PhD, MPH

Dr. Ann M. Geiger is the Scientific Director of Cancer Care Delivery Research in the NCI Community Oncology Research Program, where she leads trans-NCI efforts to develop a robust portfolio of research aimed improving outcomes for cancer patients and survivors who receive care in the community. She previously served as Acting Associate Director, and then the permanent Deputy Associate Director, of the newly formed Healthcare Delivery Research Program, with responsibility for developing a scientific vision, establishing efficient operations, and nurturing a collegial culture for this new group. In addition, Dr. Geiger serves as the Executive Secretary for the NIH-Wide Outcomes Effectiveness Research Interest Group and Senior Editor and NCI Liaison at the Journal of the National Cancer Institute. She has received a NIH Director’s Award and two NCI Director’s Awards during her tenure.

Before joining NCI, Dr. Geiger worked in both academic and delivery system settings. She spent seven years on the faculty of Wake Forest University School of Medicine where, in addition to conducting research focused on cancer survivorship, she served as Co-Director of the Graduate Program in Clinical and Translational Sciences. Prior to that position, Dr. Geiger was a scientist at Kaiser Permanente Southern California for ten years, where she collaborated with clinicians and institutional leaders to conduct practice-based research focused on cancer screening, treatment outcomes, and quality of life. She has co-authored over 120 publications and participated in numerous peer reviews of manuscripts and grant applications. Dr. Geiger earned an A.B. in Biology from Harvard-Radcliffe College and a M.P.H. and Ph.D. in Epidemiologic Science from the University of Michigan.